Maxipime (MAXI-peem, cefepime), the first "fourth-generation" injectable cephalosporin
Bristol-Myers Squibb is launching Maxipime (MAXI-peem, cefepime), the first "fourth-generation" injectable cephalosporin.
In general, the first-generation agents are primarily active against gram-positive bacteria.
Second and third generations have increasing gram-negative coverage...sometimes at the expense of reduced gram-positive activity.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote